Projet ERC-2013-CoG – 616050_MyeloSHOCK – Role of myeloid cells, their mediators and their antibody receptors in allergic shock (anaphylaxis) using humanized mouse models and clinical samples Pierre Bruhns
Projet DROPmAbs – Deep-mining of antibody repertoires using droplet-based microfluidics combined with barcoded deep sequencing for diagnostics and therapeutic antibody discovery Pierre Bruhns
Projet Role of platelets and their interactions in allergic diseases Friederike Jönsson • Pierre Bruhns
Projet Clinical and pathological consequences of human anti-drug antibodies (NASA study) Pierre Bruhns
Projet Developing novel models of disease and vaccination in Ab- and FcR-humanized mice Pierre Bruhns
Projet REEMFOAMY : Human infection with zoonotic simian foamy retroviruses: role of virological and immunological factors in restricting viral emergence Florence Buseyne • Antoine Gessain • Olivier Schwartz
Projet The role of a gradient of the chemokine CXCL12 in hematopoietic development and in a normal immune response. (Collaboration with F. Arenzana-Seisdedos, granted ANR funding) Paulo Vieira
Brevet USE OF ANTl-FcyRI AND/OR ANTl-FcyRllA ANTIBODIES FOR TREATING ARTHRITIS, INFLAMMATION, THROMBOCYTOPENIA AND ALLERGIC SHOCK Pierre Bruhns